Fractyl Health: Speculative Buy With Binary Risk

Fractyl Health, Inc. (NASDAQ: GUTS ) has a classic biotech setup at the moment. Near-term catalyst? Check. Floor level valuation? Check. Asymmetric risk-reward? Check. Current market prices reflect investor anxiety over a capital raise that it needs this year. However, the probability of success ofAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, ...